welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- log in
Small Molecule Therapies
Muscular dystrophy is the name given to a group of inherited diseases characterized by progressive muscle weakness and wasting. Current therapies can help manage the symptoms of the disease, and slow down its progression, but cannot cure it. However, there are several experimental treatments such as small molecule therapies that are being investigated and have the potential to vastly improve the symptoms.
Small molecules are compounds with low molecular weights that can easily enter cells and directly affect the target, which may be a protein or other molecules within the cell. More than 90% of the therapeutics made today are small molecules.
Some of the small molecules being studied as potential muscular dystrophy therapies are summarized below, grouped by their mechanism of action.
other Duchenne content
-
Physical Activity Level of Norwegian Boys With Duchenne Muscular DystrophyThe aim of this population based study i...
-
Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201Wave Life Sciences Ltd., a biotechnology...
-
A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne M...This is a Phase 2 randomized, 2-period, ...
-
Sarepta Therapeutics and Clinigen launch a managed access program to treat patients with Duchenne muscular dystrophy...Sarepta Therapeutics, Inc., a U.S. bioph...
-
Safety and Tolerability of Ataluren in a Phase 3 Study of Patients with Nonsense Mutation Duchenne Muscular Dystroph...Objective: Examine the safety/tolerabil...
-
The Effect of Steroid Treatment on Weight in Nonambulatory Males with Duchenne Muscular DystrophyTo describe the long-term effect of ster...
-
Matthew Wood, PhDMatthew Wood is Professor of Neuroscienc...
